180 related articles for article (PubMed ID: 37812417)
1. Venous Thromboembolism After COVID-19 Infection Among People With and Without Immune-Mediated Inflammatory Diseases.
Khan R; Kuenzig ME; Tang F; Im JHB; Widdifield J; McCurdy JD; Kaplan GG; Benchimol EI
JAMA Netw Open; 2023 Oct; 6(10):e2337020. PubMed ID: 37812417
[TBL] [Abstract][Full Text] [Related]
2. Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing.
Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
Arthritis Care Res (Hoboken); 2023 Feb; 75(2):317-325. PubMed ID: 34486829
[TBL] [Abstract][Full Text] [Related]
3. Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J
Lancet Digit Health; 2024 May; 6(5):e309-e322. PubMed ID: 38670740
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19.
Fang MC; Reynolds K; Tabada GH; Prasad PA; Sung SH; Parks AL; Garcia E; Portugal C; Fan D; Pai AP; Go AS
JAMA Netw Open; 2023 Mar; 6(3):e232338. PubMed ID: 36912838
[TBL] [Abstract][Full Text] [Related]
5. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Gulati S; Hsu CY; Shah S; Shah PK; Zon R; Alsamarai S; Awosika J; El-Bakouny Z; Bashir B; Beeghly A; Berg S; de-la-Rosa-Martinez D; Doroshow DB; Egan PC; Fein J; Flora DB; Friese CR; Fromowitz A; Griffiths EA; Hwang C; Jani C; Joshi M; Khan H; Klein EJ; Heater NK; Koshkin VS; Kwon DH; Labaki C; Latif T; McKay RR; Nagaraj G; Nakasone ES; Nonato T; Polimera HV; Puc M; Razavi P; Ruiz-Garcia E; Saliby RM; Shastri A; Singh SRK; Tagalakis V; Vilar-Compte D; Weissmann LB; Wilkins CR; Wise-Draper TM; Wotman MT; Yoon JJ; Mishra S; Grivas P; Shyr Y; Warner JL; Connors JM; Shah DP; Rosovsky RP;
JAMA Oncol; 2023 Oct; 9(10):1390-1400. PubMed ID: 37589970
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study.
Galloway J; Barrett K; Irving P; Khavandi K; Nijher M; Nicholson R; de Lusignan S; Buch MH
RMD Open; 2020 Sep; 6(3):. PubMed ID: 32994362
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19.
Xie J; Prats-Uribe A; Feng Q; Wang Y; Gill D; Paredes R; Prieto-Alhambra D
JAMA Intern Med; 2022 Oct; 182(10):1063-1070. PubMed ID: 35980616
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
J Rheumatol; 2022 May; 49(5):523-530. PubMed ID: 35105713
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data.
Merola JF; Ertmer B; Liang H; Yue X; Ofori S; Krueger W
J Am Acad Dermatol; 2024 May; 90(5):935-944. PubMed ID: 38147900
[TBL] [Abstract][Full Text] [Related]
10. Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care.
Syed U; Subramanian A; Wraith DC; Lord JM; McGee K; Ghokale K; Nirantharakumar K; Haroon S
BMC Med; 2023 Sep; 21(1):363. PubMed ID: 37735654
[TBL] [Abstract][Full Text] [Related]
11. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Bowel Disease Increases the Risk of Venous Thromboembolism in Children: A Population-Based Matched Cohort Study.
Kuenzig ME; Bitton A; Carroll MW; Kaplan GG; Otley AR; Singh H; Nguyen GC; Griffiths AM; Stukel TA; Targownik LE; Jones JL; Murthy SK; McCurdy JD; Bernstein CN; Lix LM; Peña-Sánchez JN; Mack DR; Jacobson K; El-Matary W; Dummer TJB; Fung SG; Spruin S; Nugent Z; Tanyingoh D; Cui Y; Filliter C; Coward S; Siddiq S; Benchimol EI
J Crohns Colitis; 2021 Dec; 15(12):2031-2040. PubMed ID: 34175936
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study.
Hitchon CA; Mesa C; Bernstein CN; Marrie RA; Card C; O'Brien SF; Kim J
BMJ Open; 2023 May; 13(5):e071397. PubMed ID: 37253487
[TBL] [Abstract][Full Text] [Related]
14. Association of Supernumerary Sex Chromosome Aneuploidies With Venous Thromboembolism.
Berry ASF; Finucane BM; Myers SM; Abril A; Kirchner HL; Ledbetter DH; Martin CL; Oetjens MT
JAMA; 2023 Jan; 329(3):235-243. PubMed ID: 36648468
[TBL] [Abstract][Full Text] [Related]
15. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Izadi Z; Brenner EJ; Mahil SK; Dand N; Yiu ZZN; Yates M; Ungaro RC; Zhang X; Agrawal M; Colombel JF; Gianfrancesco MA; Hyrich KL; Strangfeld A; Carmona L; Mateus EF; Lawson-Tovey S; Klingberg E; Cuomo G; Caprioli M; Cruz-Machado AR; Mazeda Pereira AC; Hasseli R; Pfeil A; Lorenz HM; Hoyer BF; Trupin L; Rush S; Katz P; Schmajuk G; Jacobsohn L; Seet AM; Al Emadi S; Wise L; Gilbert EL; Duarte-García A; Valenzuela-Almada MO; Isnardi CA; Quintana R; Soriano ER; Hsu TY; D'Silva KM; Sparks JA; Patel NJ; Xavier RM; Marques CDL; Kakehasi AM; Flipo RM; Claudepierre P; Cantagrel A; Goupille P; Wallace ZS; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Robinson PC; Machado PM; Griffiths CEM; Barker JN; Smith CH; Yazdany J; Kappelman MD; ;
JAMA Netw Open; 2021 Oct; 4(10):e2129639. PubMed ID: 34661663
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and Risk of VTE in Ethnically Diverse Populations.
Go AS; Reynolds K; Tabada GH; Prasad PA; Sung SH; Garcia E; Portugal C; Fan D; Pai AP; Fang MC
Chest; 2021 Oct; 160(4):1459-1470. PubMed ID: 34293316
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of COVID-19 Infection and Vaccination Among Individuals With Myasthenia Gravis.
Alcantara M; Koh M; Park AL; Bril V; Barnett C
JAMA Netw Open; 2023 Apr; 6(4):e239834. PubMed ID: 37097637
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis.
Widdifield J; Eder L; Chen S; Kwong JC; Hitchon C; Lacaille D; Aviña-Zubieta JA; Svenson LW; Bernatsky S
J Rheumatol; 2022 May; 49(5):531-536. PubMed ID: 35034001
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases.
Schneeweiss MC; Kim SC; Wyss R; Jin Y; Chin K; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S
JAMA Dermatol; 2021 Jul; 157(7):805-816. PubMed ID: 34037662
[TBL] [Abstract][Full Text] [Related]
20. Genetic risk and incident venous thromboembolism in middle-aged and older adults following COVID-19 vaccination.
Xie J; Prats-Uribe A; Gordillo-Marañón M; Strauss VY; Gill D; Prieto-Alhambra D
J Thromb Haemost; 2022 Dec; 20(12):2887-2895. PubMed ID: 36111372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
